Literature DB >> 1566498

Suppression of natural xenophile antibodies with the novel immunomodulating drug leflunomide.

K Ulrichs1, J Kaitschick, R Bartlett, W Müller-Ruchholtz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1566498

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Effects of leflunomide on immune responses and models of inflammation.

Authors:  R R Bartlett; H Anagnostopulos; T Zielinski; T Mattar; R Schleyerbach
Journal:  Springer Semin Immunopathol       Date:  1993

Review 2.  Prevention of transplant rejection: current treatment guidelines and future developments.

Authors:  N Perico; G Remuzzi
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

3.  Leflunomide interferes with pyrimidine nucleotide biosynthesis.

Authors:  H M Cherwinski; N Byars; S J Ballaron; G M Nakano; J M Young; J T Ransom
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

4.  Prevention of the acute graft-versus-host disease (GVHD) in rats by the immunomodulating drug leflunomide.

Authors:  C Mrowka; G H Thoenes; K H Langer; R R Bartlett
Journal:  Ann Hematol       Date:  1994-04       Impact factor: 3.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.